Literature DB >> 10553011

Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes.

F Lammert1, D Q Wang, B Paigen, M C Carey.   

Abstract

There is no consensus whether hepatic lipid regulatory enzymes play primary or secondary roles in cholesterol cholelithiasis. We have used inbred mice with Lith genes that determine cholesterol gallstone susceptibility to evaluate the question. We studied activities of regulatory enzymes in cholesterol biosynthesis (HMG-CoA reductase), cholesterol esterification (acyl-CoA:cholesterol acyltransferase) and the "neutral" (cholesterol 7alpha-hydroxylase) and "acidic" (sterol 27-hydroxylase) pathways of bile salt synthesis in strains C57L/J and SWR/J as well as recombinant inbred (AKXL-29) mice, all of which have susceptible Lith alleles, and compared them to AKR/J mice with resistant Lith alleles. We determined hepatic enzyme activities of male mice before and at frequent intervals during feeding a lithogenic diet (15% dairy fat, 1% cholesterol, 0.5% cholic acid) for 12 weeks. Basal activities on chow show significant genetic variations for HMG-CoA reductase, sterol 27-hydroxylase, and acyl-CoA: cholesterol acyltranferase, but not for cholesterol 7alpha-hydroxylase. In response to the lithogenic diet, activities of the regulatory enzymes in the two bile salt synthetic pathways are coordinately down-regulated and correlate inversely with prevalence rates of cholesterol crystals and gallstones. Compared with gallstone-resistant mice, significantly higher HMG-CoA reductase activities together with lower activities of both bile salt synthetic enzymes are hallmarks of the enzymatic phenotype in mice with susceptible Lith alleles. The most parsimonious explanation for the multiple enzymatic alterations is that the primary Lith phenotype induces secondary events to increase availability of cholesterol to supply the sterol to the hepatocyte canalicular membrane for hypersecretion into bile.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553011

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  15 in total

1.  Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Frank Lammert; Anne Schmitz; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2010-04-28       Impact factor: 4.686

2.  Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.

Authors:  Oliver Müller; Carmen Schalla; Jürgen Scheibner; Eduard F Stange; Michael Fuchs
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 3.  Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.

Authors:  Helen H Wang; Piero Portincasa; Ornella de Bari; Kristina J Liu; Gabriella Garruti; Brent A Neuschwander-Tetri; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-02-19       Impact factor: 4.686

4.  Prevalence of gallstone disease in first-degree relatives of patients with cholelithiasis.

Authors:  Adolfo-Francesco Attili; Adriano De Santis; Fabia Attili; Enrico Roda; Davide Festi; Nicola Carulli
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

Review 5.  Mouse models of gallstone disease.

Authors:  Tony Y Wang; Piero Portincasa; Min Liu; Patrick Tso; David Q-H Wang
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

6.  Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.

Authors:  G A Clarke; G Bouchard; B Paigen; M C Carey
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 7.  Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes.

Authors:  David Q-H Wang; Nezam H Afdhal
Journal:  Curr Gastroenterol Rep       Date:  2004-04

8.  Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease.

Authors:  Zhao-Yan Jiang; Tian-Quan Han; Guang-Jun Suo; Dian-Xu Feng; Sheng Chen; Xing-Xing Cai; Zhi-Hong Jiang; Jun Shang; Yi Zhang; Yu Jiang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

9.  Megalin and cubilin in the human gallbladder epithelium.

Authors:  Alexandra K Tsaroucha; Ekaterini Chatzaki; Maria Lambropoulou; Kaliopi Despoudi; Prodromos Laftsidis; Chara Charsou; Alexandros Polychronidis; Nikolaos Papadopoulos; Constantinos E Simopoulos
Journal:  Clin Exp Med       Date:  2008-09-13       Impact factor: 3.984

10.  Microarray analysis of hepatic gene expression in gallstone-susceptible and gallstone-resistant mice.

Authors:  Patricia A Dyck; Farzana Hoda; Elizabeth S Osmer; Richard M Green
Journal:  Mamm Genome       Date:  2003-09       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.